Rising Biosciences, Inc. (OTC:RBII) Files Attorney Letter to go OTC Pink Current following Release of CBD Offering.

Today Rising Biosciences, Inc. (OTC:RBII) Rising Biosciences, Inc. filed a “Attorney Letter with Respect to Current Information – RBII Attorney Opinion with Respect Current Information” , with the intention of going OTC Pink current. This comes after the company released its latest CBD offering by announcing a CBD Only Variant of Cannophen(TM) to Begin Pilot […]